Illumina Stock Price

13.05 (4.29%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Illumina Inc ILMN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
13.05 4.29% 317.03 17:00:00
Open Price Low Price High Price Close Price Previous Close
305.00 304.01 319.33 317.03 303.98
Bid Price Ask Price Spread News
306.00 317.00 11.00 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
18,096 981,685 $ 313.82 $ 308,073,781 1,151,285 196.78 - 404.20
Last Trade Time Type Quantity Stock Price Currency
16:36:03 formt 316 $ 317.03 USD

Illumina Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 46.29B 146.00M 127.71M $ 3.54B $ 697.97M 6.75 70.90
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% -43.39k 2.10%

more financials information »

Illumina News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ILMN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week300.00319.33297.21303.05819,01217.035.68%
1 Month308.59319.55288.01300.891,212,7028.442.74%
3 Months346.06376.67261.01306.421,595,758-29.03-8.39%
6 Months354.62404.20261.01329.841,202,920-37.59-10.6%
1 Year319.82404.20196.78312.011,206,654-2.79-0.87%
3 Years215.00404.20196.78301.021,033,866102.0347.46%
5 Years180.72404.20119.37243.241,070,026136.3175.43%

Illumina Description

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (73% of 2019 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 17% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.